Literature DB >> 23792738

Stereotactic injection of microRNA-expressing lentiviruses to the mouse hippocampus ca1 region and assessment of the behavioral outcome.

Shahar Barbash1, Geula Hanin, Hermona Soreq.   

Abstract

MicroRNAs (miRNAs) are small regulatory single-stranded RNA molecules around 22 nucleotides long that may each target numerous mRNA transcripts and dim an entire gene expression pathway by inducing destruction and/or inhibiting translation of these targets. Several miRNAs play key roles in maintaining neuronal structure and function and in higher-level brain functions, and methods are sought for manipulating their levels for exploring these functions. Here, we present a direct in vivo method for examining the cognitive consequences of enforced miRNAs excess in mice by stereotactic injection of miRNA-encoding virus particles. Specifically, the current protocol involves injection into the hippocampal CA1 region, which contributes to mammalian memory consolidation, learning, and stress responses, and offers a convenient injection site. The coordinates are measured according to the mouse bregma and virus perfusion is digitally controlled and kept very slow. After injection, the surgery wound is sealed and the animals recover. Lentiviruses encoding silencers of the corresponding mRNA targets serve to implicate the specific miRNA/target interaction responsible for the observed effect, with naïve mice, mice injected with saline and mice injected with "empty" lentivirus vectors as controls. One month post-injection, the animals are examined in the Morris Water Maze (MWM) for assessing their navigation learning and memory abilities. The MWM is a round tank filled with colored water with a small platform submerged 1 cm below the water surface. Steady visual cues around the tank allow for spatial navigation (sound and the earth's magnetic field may also assist the animals in navigating). Video camera monitoring enables measuring the route of swim and the time to find and amount the platform. The mouse is first taught that mounting the hidden platform offers an escape from the enforced swimming; it is then tested for using this escape and finally, the platform is removed and probe tests examine if the mouse remembers its previous location. Repeated tests over several consecutive days highlight improved performance of tested mice at shorter latencies to find and mount the platform, and as more direct routes to reach the platform or its location. Failure to show such improvement represents impaired learning and memory and/or anxiety, which may then be tested specifically (e.g. in the elevated plus maze). This approach enables validation of specific miRNAs and target transcripts in the studied cognitive and/or stress-related processes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23792738      PMCID: PMC3727175          DOI: 10.3791/50170

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  13 in total

1.  Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.

Authors:  Amy Mendenhall; Jacob Lesnik; Chandreyee Mukherjee; Travis Antes; Ranjita Sengupta
Journal:  J Vis Exp       Date:  2012-04-08       Impact factor: 1.355

2.  Genetic approach for intracerebroventricular delivery.

Authors:  Limor Regev; Eli Ezrielev; Eran Gershon; Shosh Gil; Alon Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

3.  MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34.

Authors:  Sharon Haramati; Inbal Navon; Orna Issler; Gili Ezra-Nevo; Shosh Gil; Raaya Zwang; Eran Hornstein; Alon Chen
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

4.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway.

Authors:  Peng Jin; Daniela C Zarnescu; Stephanie Ceman; Mika Nakamoto; Julie Mowrey; Thomas A Jongens; David L Nelson; Kevin Moses; Stephen T Warren
Journal:  Nat Neurosci       Date:  2004-01-04       Impact factor: 24.884

5.  A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis.

Authors:  Gabriele Siegel; Gregor Obernosterer; Roberto Fiore; Martin Oehmen; Silvia Bicker; Mette Christensen; Sharof Khudayberdiev; Philipp F Leuschner; Clara J L Busch; Christina Kane; Katja Hübel; Frank Dekker; Christian Hedberg; Balamurugan Rengarajan; Carsten Drepper; Herbert Waldmann; Sakari Kauppinen; Michael E Greenberg; Andreas Draguhn; Marc Rehmsmeier; Javier Martinez; Gerhard M Schratt
Journal:  Nat Cell Biol       Date:  2009-05-24       Impact factor: 28.824

6.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

Authors:  O Boussif; F Lezoualc'h; M A Zanta; M D Mergny; D Scherman; B Demeneix; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

7.  In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice.

Authors:  A Consiglio; A Quattrini; S Martino; J C Bensadoun; D Dolcetta; A Trojani; G Benaglia; S Marchesini; V Cestari; A Oliverio; C Bordignon; L Naldini
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

8.  Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target.

Authors:  G Shaltiel; M Hanan; Y Wolf; S Barbash; E Kovalev; S Shoham; H Soreq
Journal:  Brain Struct Funct       Date:  2012-01-14       Impact factor: 3.270

9.  Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice.

Authors:  Amit Berson; Shahar Barbash; Galit Shaltiel; Yael Goll; Geula Hanin; David S Greenberg; Maya Ketzef; Albert J Becker; Alon Friedman; Hermona Soreq
Journal:  EMBO Mol Med       Date:  2012-05-25       Impact factor: 12.137

10.  Morris Water Maze Experiment.

Authors:  Joseph Nunez
Journal:  J Vis Exp       Date:  2008-09-24       Impact factor: 1.355

View more
  6 in total

1.  A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA.

Authors:  Hemant Suryawanshi; Mayuresh Anant Sarangdhar; Manika Vij; Reema Roshan; Vijay Pal Singh; Munia Ganguli; Beena Pillai
Journal:  J Vis Exp       Date:  2015-12-26       Impact factor: 1.355

2.  Sirt1 protects against hippocampal atrophy and its induced cognitive impairment in middle-aged mice.

Authors:  Zuhao Sun; Shuang Zhao; Xinjun Suo; Yan Dou
Journal:  BMC Neurosci       Date:  2022-06-06       Impact factor: 3.264

3.  Effects of microRNA-21 and microRNA-24 inhibitors on neuronal apoptosis in ischemic stroke.

Authors:  Wansheng Liu; Xiaosheng Chen; Yu Zhang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 4.  microRNAs in nociceptive circuits as predictors of future clinical applications.

Authors:  Michaela Kress; Alexander Hüttenhofer; Marc Landry; Rohini Kuner; Alexandre Favereaux; David Greenberg; Josef Bednarik; Paul Heppenstall; Florian Kronenberg; Marzia Malcangio; Heike Rittner; Nurcan Uçeyler; Zlatko Trajanoski; Peter Mouritzen; Frank Birklein; Claudia Sommer; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2013-10-17       Impact factor: 5.639

5.  Competing targets of microRNA-608 affect anxiety and hypertension.

Authors:  Geula Hanin; Shani Shenhar-Tsarfaty; Nadav Yayon; Yin Hoe Yau; Yau Yin Hoe; Estelle R Bennett; Ella H Sklan; Dabeeru C Rao; Tuomo Rankinen; Claude Bouchard; Susana Geifman-Shochat; Sagiv Shifman; David S Greenberg; Hermona Soreq
Journal:  Hum Mol Genet       Date:  2014-04-09       Impact factor: 6.150

6.  Endophilin A1 Promotes Actin Polymerization in Dendritic Spines Required for Synaptic Potentiation.

Authors:  Yanrui Yang; Jiang Chen; Zhenzhen Guo; Shikun Deng; Xiangyang Du; Shaoxia Zhu; Chang Ye; Yun S Shi; Jia-Jia Liu
Journal:  Front Mol Neurosci       Date:  2018-05-28       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.